Becton, Dickinson and Company BDX
183.82
4.59
2.56%
as of 25 Sep
- Market cap
- $48.8B
- P/E
- 55.4×
Follow BDX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Becton, Dickinson and Company (BDX) Shares outstanding
Becton, Dickinson and Company's shares outstanding at the end of fiscal 2025 was $288.5M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $275.2M. Over the past ten years it has ranged from $207.5M (fiscal 2015) to $292.1M (fiscal 2021); the current reading is higher than 82% of that period. Becton, Dickinson and Company ranks 7th of 51 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Annual
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $288.5M | (0.86%) |
| FY2024 | $291.0M | 0.91% |
| FY2023 | $288.4M | 0.36% |
| FY2022 | $287.4M | (1.62%) |
| FY2021 | $292.1M | 3.43% |
| FY2020 | $282.4M | 2.78% |
| FY2019 | $274.8M | 3.84% |
| FY2018 | $264.6M | 18.35% |
| FY2017 | $223.6M | 2.78% |
| FY2016 | $217.5M | 4.83% |
Quarterly
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $275.2M | (1.95%) |
| Mar 2026 | $280.6M | (1.82%) |
| Dec 2025 | $285.8M | (0.92%) |
| Sep 2025 | $288.5M | 0.45% |
| 42 more quarters | Free account |
Against its own ten years
Low $207.5M
High $292.1M
Ten-year median
$282.4M
Current reading's percentile
82
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| MDLN Medline Inc. compare | $861.0M |
| BAX Baxter International Inc. compare | $518.0M |
| ALC Alcon compare | $488.7M |
| ISRG Intuitive Surgical, Inc. compare | $357.3M |
| BDX Becton, Dickinson and Company | $275.2M |
| SOLV Solventum Corporation compare | $173.3M |
| RMD ResMed Inc. compare | $146.1M |
| WST West Pharmaceutical Services, Inc. compare | $71.3M |
| RGEN Repligen Corporation compare | $56.6M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on BDX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- The full statement